
Episode 50: Finalized 340B Rules, Midterm Congressional Shakeups and a CVS Break Up
In this episode, 340B Report Publisher and CEO Ted Slafsky joins Editor-in-Chief Will Newton, Managing Editor Shannon Young and National Correspondent Luke Zarzecki in breaking down the latest 340B news, including two new Centers for Medicare and Medicaid Services (CMS) final rules with major 340B implications; what the 2026 congressional midterm elections could mean for the future of 340B policy; and CVS Health's surprise move to split off its businesses into two companies. Ted also reflects on Inside 340B Report's 50th episode milestone and thanks the behind-the-scenes team that makes sure listeners can benefit from this show.
Key Topics Covered:
CMS Releases Final Rules Affecting 340B
Will breaks down the new CMS rule to slash Medicare Part B reimbursement to certain types of 340B hospitals by around 32% starting next year. Ted looks back at the previous efforts to block the first Trump administration's Part B cuts and predicts there will be similar legal and legislative efforts this time as well. Will also explains CMS' other new rule creating a mandatory 340B data repository for Part D claims, including how it differs from other reporting requirements.
Congressional Bills and Midterm Outcomes
Shannon, Luke and Ted discuss the outcomes of the historic midterm elections and what they could mean for 340B policy on Capitol Hill in 2027. Shannon highlights key races in the U.S. House, while Luke breaks down the results from the U.S. Senate. Ted offers insights into what 340B observers could expect to see happen on the policy front in the 120th Congress. The three also discuss two recently introduced federal bills that would halt the Trump administration's 340B rebate model pilot from taking effect as planned on Jan. 1, 2027.
CVS Breaks Up
Will details CVS Health's recently announced move to split into two separate companies in 2028, and what that could mean for 340B stakeholders. He also notes that CVS' 340B practices have faced increasing scrutiny, including from a series of health system lawsuits alleging the company conspired to lower 340B contract pharmacy reimbursement owed to those hospitals. Will notes that CVS has denied those claims.
Subscribe & Stay Updated
How to Follow Us and Learn More About This Episode's Sponsor
Stay tuned for more episodes every other week! 🎧Subscribe to Inside 340B Report on your favorite podcast platform or YouTube.
This episode is brought to you by one of our great Ultra Diamond sponsors, Pillr Health. Pillr is a leading provider of innovative solutions designed to optimize and streamline pharmacy operations with a focus on enhancing efficiency, reducing costs and improving patient outcomes, particularly within the 340B program. We are very grateful to Pillr Health for its sponsorship.
Subscribe to 340B Report with a Special Discount
We're offering a special discount for podcast listeners. 340B Report is the indispensable source for news and intelligence on the 340B program. First-time subscribers may subscribe now using coupon code PODCAST25. Not ready to subscribe? Sign up for a 15-day free trial.
More episodes from "Inside 340B Report"



Don't miss an episode of “Inside 340B Report” and subscribe to it in the GetPodcast app.








